scispace - formally typeset
L

Lou F. M. H. de Leij

Researcher at University of Groningen

Publications -  73
Citations -  3621

Lou F. M. H. de Leij is an academic researcher from University of Groningen. The author has contributed to research in topics: Antigen & Monoclonal antibody. The author has an hindex of 34, co-authored 73 publications receiving 3503 citations. Previous affiliations of Lou F. M. H. de Leij include University Medical Center Groningen.

Papers
More filters
Journal ArticleDOI

EpCAM in carcinogenesis: the good, the bad or the ugly

TL;DR: The controversial biological role of EpCAM is described with the focus on carcinogenesis: as an adhesion molecule, EpCam mediates homophilic adhesion interactions, which in turn might prevent metastasis, and epigenetic editing is proposed as a novel approach to investigate the biological role.
Journal ArticleDOI

In Vivo Characteristics of Cationic Liposomes as Delivery Vectors for Gene Therapy

TL;DR: This review gives a concise overview of studies on the application of cationic liposomes in vivo in animal models of diseases and in clinical studies, and discusses the transfection efficiency, the pharmacokinetic and pharmacodynamic properties of the lipid-DNA complexes, and potentially relevant applications for cationo- DNA complexes.
Journal ArticleDOI

CYP2D6 and CYP2C19 activity in a large population of Dutch healthy volunteers: indications for oral contraceptive-related gender differences

TL;DR: In EM females compared to EM males, CYP2D6 activity is increased and CyP2C19 activity is reduced, and this reduction is substantial and most pronounced in the age range from 18 to 40 years.
Journal ArticleDOI

Targeted induction of apoptosis for cancer therapy: current progress and prospects

TL;DR: Recent progress and prospects of selected novel anti-cancer approaches that specifically target and sensitize cancer cells to apoptosis are reviewed.